BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28105437)

  • 1. Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma.
    Prokopowicz G; Życzkowski M; Nowakowski K; Bogacki R; Bryniarski P; Paradysz A
    Biomed Res Int; 2016; 2016():8687575. PubMed ID: 28105437
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up.
    Życzkowski M; Prokopowicz G; Taborowski P; Nowakowski K; Rajwa P; Stelmach P; Paradysz A
    Med Sci Monit; 2018 Jun; 24():3895-3902. PubMed ID: 29885161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
    Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
    Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy.
    Życzkowski M; Kaletka Z; Rajwa P; Rempega G; Stelmach P; Bogacki R; Łach-Wojnarowicz O; Paradysz E
    Int Urol Nephrol; 2020 May; 52(5):885-891. PubMed ID: 31953718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma.
    Lughezzani G; Karakiewicz PI; Bigot P; Perrotte P; Crépel M; Rioux-Leclercq N; Catros-Quemener V; Moulinoux JP; Bouet F; Cipolla B; Patard JJ
    Eur J Cancer; 2010 Jul; 46(10):1927-35. PubMed ID: 20335019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
    Wosnitzer M; Polland A; Hai Q; Hruby G; McKiernan J
    BJU Int; 2011 Jul; 108(1):73-9. PubMed ID: 21166746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
    Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of preoperative platelet count in patients with gallbladder cancer.
    Wang RT; Zhang LQ; Mu YP; Li JB; Xu XS; Pang Q; Sun LK; Zhang X; Dong SB; Wang L; Liu C
    World J Gastroenterol; 2015 May; 21(17):5303-10. PubMed ID: 25954104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
    Karakiewicz PI; Trinh QD; Lam JS; Tostain J; Pantuck AJ; Belldegrun AS; Patard JJ
    Eur Urol; 2007 Nov; 52(5):1428-36. PubMed ID: 17420085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial comment on: Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
    Bex A
    Eur Urol; 2007 Nov; 52(5):1436-7. PubMed ID: 17420089
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
    Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
    Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma.
    Keskin S; Keskin Z; Taskapu HH; Kalkan H; Kaynar M; Poyraz N; Toy H
    BMC Urol; 2014 Nov; 14():95. PubMed ID: 25427576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to recurrence after nephrectomy as a predictor of cancer-specific survival in localized clear-cell renal cell carcinoma.
    Rodriguez-Covarrubias F; Gomez-Alvarado MO; Sotomayor M; Castillejos-Molina R; Mendez-Probst CE; Gabilondo F; Feria-Bernal G
    Urol Int; 2011; 86(1):47-52. PubMed ID: 20814191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy.
    Jeon HG; Choi DK; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Ann Surg Oncol; 2016 Jan; 23(1):321-7. PubMed ID: 26045392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.